Purificación García-Miguel-rekin lankidetzan egindako argitalpenak (18)

2016

  1. A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility

    Pediatric Research, Vol. 80, Núm. 4, pp. 472-479

  2. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

    Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741

2014

  1. Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility

    Pediatric Research, Vol. 75, Núm. 6, pp. 767-773

  2. Pharmacogenetics of MicroRNAs and MicroRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Intron 3 of the ARID5B gene: A hot spot for acute lymphoblastic leukemia susceptibility

    Journal of Cancer Research and Clinical Oncology, Vol. 139, Núm. 11, pp. 1879-1886

  2. Polymorphisms in the methotrexate transport pathway: A new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia

    Pharmacogenetics and Genomics, Vol. 23, Núm. 2, pp. 53-61

2012

  1. T-cell pediatric acute lymphoblastic leukemia: Analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP

    Medicina Clinica, Vol. 139, Núm. 4, pp. 141-149

2011

  1. Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia

    Pediatric Blood and Cancer, Vol. 57, Núm. 4, pp. 612-619

2007

  1. Resultados del protocolo SHOP LNHB98 (LMB89) en pacientes de edad pediátrica afectados de linfoma no hodgkiniano de células B

    Medicina Clinica, Vol. 128, Núm. 17, pp. 641-646

2006

  1. Diagnóstico molecular del retinoblastoma: Epidemiología molecular y consejo genético

    Medicina Clinica, Vol. 126, Núm. 11, pp. 401-405

2005

  1. Erratum: Resultados terapéuticos en la leucemia linfoblástica aguda infantil con los protocolos SHOP de la Sociedad Española de Hematología Pediátrica (SEHP) y la Sociedad Española de Oncología Pediátrica (SEOP). 1989-2005 (Revista Espanola de Pediatria (2005) 61, 4 (273))

    Revista Espanola de Pediatria

  2. Identification of 26 new constitutional RB1 gene mutations in Spanish, Colombian, and Cuban retinoblastoma patients.

    Human mutation, Vol. 25, Núm. 1, pp. 99

2001

  1. Five novel single nucleotide polymorphisms of the RB1 gene (g.5625T>C, g.70169T>G, g.76875A>T, g.78026delA, and g.150072T>C) in retinoblastoma patients.

    Human mutation, Vol. 17, Núm. 5, pp. 437

  2. Protocolo de estudio y tratamiento de la leucemia aguda linfoblástica en pediatría (LAL/SHOP-99)

    Revista Espanola de Pediatria, Vol. 57, Núm. 342, pp. 523-533

2000

  1. Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma

    Medical and Pediatric Oncology

1999

  1. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting

    European Journal of Cancer, Vol. 35, Núm. 4, pp. 606-611

1995

  1. Stage IV neuroblastoma in children over 1 year of age: Results of a cooperative study using high-dose cisplatin-VM/26 and cyclophosphamide-doxorubicin as initial therapy

    International Journal of Pediatric Hematology/Oncology, Vol. 2, Núm. 3, pp. 255-262

  2. The treatment of advanced neuroblastoma. Results of the spanish neuroblastoma study group (SNSG) studies

    European Journal of Cancer, Vol. 31, Núm. 4, pp. 642-645